$1.03
0.010.98%
Ult. Agg.: Nov 6, 7:59 PM
The average analyst price target for Spero Therapeutics is $5.67, 455.9% above the current price. Of 4 analysts, 2 rate it Buy and 2 Hold. Targets range from $5 to $6. The latest change came on Oct 28, 2026, when Cantor Fitzgerald initiated coverage of Spero Therapeutics with an Overweight rating and a $6 price target.
Price Target Range — 8 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months